Prostate Cancer - Results from #27260

Promoting wellness for patients on androgen deprivation therapy: Why using numerous drugs for drug side effects should not be first-line treatment - Abstract August 22, 2011

Prostate imaging modalities that can be used for complementary and alternative medicine clinical studies - Abstract August 22, 2011

Investigation of dose perturbations and the radiographic visibility of potential fiducials for proton radiation therapy of the prostate - Abstract August 22, 2011

Editor's Commentary - Optimizing prostate cancer detection during biopsy by standardizing the amount of tissue examined per core August 22, 2011

The evolution of rectal and urinary toxicity and immune response in prostate cancer patients treated with two three-dimensional conformal radiotherapy techniques - Abstract August 19, 2011

Low-dose diethylstilbestrol for the treatment of advanced prostate cancer - Abstract August 19, 2011

Combination of docetaxel and vandetanib in docetaxel-sensitive or resistant PC3 cell line - Abstract August 19, 2011

Perineural invasion detection in prostate biopsy is related to recurrence-free survival in patients submitted to radical prostatectomy - Abstract August 19, 2011

Pretreatment depressive symptoms and treatment modality predict post-treatment disease-specific quality of life among patients with localized prostate cancer - Abstract August 19, 2011

Alternative antiandrogen therapy with flutamide in patients with castration-resistant prostate cancer : A single center experience - Abstract August 19, 2011

Co-administration of piperine and docetaxel results in improved anti-tumor efficacy via inhibition of CYP3A4 activity - Abstract August 19, 2011

Editor's Commentary - The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy August 19, 2011

Validation of the modified American Urological Association symptom score - Abstract August 18, 2011

ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of anti-hormonal therapy - Abstract August 18, 2011

Transrectal high-intensity focused ultrasound for local treatment of prostate cancer: Current role - Abstract August 18, 2011

Sipuleucel-T for therapy of asymptomatic or minimally symptomatic, castrate-refractory prostate cancer: An update and perspective among other treatments - Abstract August 18, 2011

Progress against cancer in the Netherlands since the late 1980s: An epidemiological evaluation - Abstract August 18, 2011

Utilization trends in prostate cancer therapy - Abstract August 17, 2011

Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens - Abstract August 17, 2011

False-positive screening results in the European Randomized Study of Screening for Prostate Cancer - Abstract August 17, 2011

Page 1364 of 1435